Why the study?
Venous thromboembolism is associated with cancer and pulmonary embolism causes significant morbidity and mortality, prompting an evaluation of clinical characteristics, laboratory findings, radiology features, and outcomes in cancer patients with PE.
Population
60 adult cancer patients diagnosed with PE by computed tomography pulmonary angiography
Design
Cross-sectional study
Follow-up
6 months
Authors
Loading...
Potential biomarkers for asymptomatic PE in cancer identified; leaves open need for prospective validation before clinical adoption.
Elevated lactic acid and platelet counts, along with low CEA, albumin, and D-dimer levels, may serve as potential biomarkers for detecting asymptomatic pulmonary embolism in cancer patients.
Chlapoutakis et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: